2022 annual financial data
Coherus Oncology 2022 Net margin
Direct answer
Net margin was -138.24%.
Operating income was -256,880,000 USD and net income was -291,754,000 USD.
Operating cash flow was -241,124,000 USD.
Get free Coherus Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 211,042,000 USD
- Operating income
- -256,880,000 USD
- Net income
- -291,754,000 USD
- Operating cash flow
- -241,124,000 USD